Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

1.4800

+0.0300

(+2.07%)

At close: 04:00PM EDT

1.4700

-0.01

(-0.68%)

After hours:

07:59PM EDT

Loading interactive chart…

Simply Wall St.
The Clovis Oncology, Inc. (NASDAQ:CLVS) Analysts Have Been Trimming Their Sales Forecasts
Today is shaping up negative for Clovis Oncology, Inc. ( NASDAQ:CLVS ) shareholders, with the analysts delivering a...
Motley Fool
Why Clovis Oncology Stock Is Sinking Today
Shares of the cancer drugmaker Clovis Oncology (NASDAQ: CLVS) are under pressure yet again today. After this latest dip, Clovis' stock is down by over 46% for the year. The biotech released its 2022 second-quarter earnings report ahead of the opening bell Monday morning, and its latest financial results aren't a hit with shareholders.
Zacks
Clovis (CLVS) Q2 Loss Wider Than Expected, Revenues Miss
Clovis (CLVS) incurs a wider-than-estimated loss in second-quarter 2022. Sales of the sole marketed drug Rubraca decline year over year due to COVID-19 impacts. CLVS faces the risk of a cash crunch.